Methotrexate
- Product NDC
- 67457-466
- 11-digit product format
- 674570466
- Labeler code
- 67457
- Product ID
- 67457-466_6c8884a0-d167-48a8-a890-7bf72054d72b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- INJECTION
- Route
- INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA201529
- Marketing category
- ANDA
- Marketing start
- 2012-03-30
- Marketing end
- 2021-04-30
- Substance
- METHOTREXATE SODIUM
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-466-10 | 67457046610 | 1 VIAL in 1 CARTON (67457-466-10) > 10 mL in 1 VIAL | 1 vial | 2012-03-30 | 2021-04-30 | No | No | Current |